KITSO Research Group

KI-gestützte Therapiestratifizierung in der Onkologie

The KITSO group develops computational and machine learning approaches for personalized cancer therapy stratification. We are part of the Department of Radiation Oncology at LMU Hospital and the Faculty of Medicine at Ludwig-Maximilians-Universität Munich.

Research

Our main aim is to integrate multi-omics data, medical imaging, and clinical information to develop predictive models that support treatment decisions in oncology. We focus on translational applications that can directly impact patient care.

Here are some research areas in which we are actively involved:

Radiomics and Medical Imaging
Development of AI models for quantitative analysis of CT, MRI, and PET imaging data to support radiation therapy planning, treatment response assessment, and outcome prediction.

Digital Pathology
Application of deep learning methods to histopathological images for automated tissue classification, biomarker discovery, and integration with molecular data.

Multi-omics Data Integration
Computational frameworks for integrating genomic, transcriptomic, and proteomic data to characterize tumor heterogeneity and identify therapeutic vulnerabilities.

Clinical Decision Support
Translation of predictive models into clinical workflows, with emphasis on interpretability and validation in prospective cohorts.

Collaborations

We have the privilege of collaborating with a number of excellent clinical, pathology, experimental medical physics, and artificial intelligence research groups at Ludwig-Maximilians-Universität, Helmholtz Munich, the Munich Center for Machine Learning, and other universities, research institutions, and hospitals across Germany. Our recent and current collaborators include Carsten Marr, Horst Zitzelsberger, Guillaume Landry, Olivier Gires, Julia Heß, and Patrick Harter.

News